Will either Moody's or S&P downgrade LYB's senior unsecured rating by year-end 2026?
Current Prediction
Why This Question Matters
Tests the downside tail of the funding-fragility storyline. LYB is rated Baa2/BBB; $8.1B liquidity is a defensive cushion but the $(738)M FY2025 GAAP loss and elevated capex produce negative FCF pressure. A downgrade by either Moody's or S&P signals that agencies view the cycle as extending meaningfully longer than management suggests. No downgrade supports the FUNDING_FRAGILITY ADEQUATE classification. This is a structured probe of the 25% extended-cycle probability path.
Prediction Distribution
Individual Predictions(9 runs)
Committee labels FUNDING_FRAGILITY as ADEQUATE; $8.1B liquidity + $1.5B pre-funding + 95% cash conversion are rating-positive. Expected Feb 2026 dividend cut (separate market ~60% prob of 40%+ cut) directly relieves rating pressure. Agencies have shown patience through 2024-2025 trough without action. However: BASF was downgraded 2024 during similar cycle; cycle extension through 2026 could trigger BBB→BBB- action by S&P or Baa2→Baa3 by Moody's. Base rate for BBB cyclical downgrade during extended trough ~25-35%. Settle 0.28 reflecting moderate tail risk.
Rating-positive factors dominate: $8.1B liquidity is strong cushion; pre-funding executed; operational discipline credible (VEP, CIP); committee's ADEQUATE funding assessment. Dividend cut defuses primary pressure mechanism. Agencies typically require sustained multi-year evidence for IG downgrade; LYB's cycle is at trough now so even if cycle extends through 2026, agency decision typically lags into 2027. 0.20-0.28. Settle 0.25.
Two-way risk: (1) If dividend cut is not large enough (< 40% in separate market, ~40% probability), if Saudi JV commitment accelerates (low probability), if European divestiture proceeds fall short — compounding pressure could trigger downgrade. (2) If Q1 EBITDA disappoints, adds negative momentum. Base rate for Baa2/BBB during extended chemical cycle trough is ~30%. Meta placed credit reviews as Q2-Q4 2026 monitoring trigger, implying possibility is real. Settle 0.30.
Committee labels ADEQUATE not STRAINED; cushion is real; dividend lever active. Downgrade probability moderate at 20-30%. 0.25 central.
Model Moody's and S&P independently: P(Moody's downgrade) ~15%, P(S&P downgrade) ~15-20%. Union with ~10% correlation ~25-28%. Settle 0.28.
Conservative: liquidity cushion, dividend discretion, and operational credibility argue against near-term downgrade. Agency lag typical. 0.20-0.25.
Moderate probability 25-30%. Committee ADEQUATE + dividend lever + patience already shown argue against; extended cycle + GAAP loss could still trigger. 0.27.
25% reflects balance between funding-adequate baseline and extended-cycle tail risk.
Base rate 25-30% for BBB/Baa2 during extended trough. Settle 0.28.
Resolution Criteria
Resolves YES if either Moody's Investors Service or S&P Global Ratings publishes a rating action between 2026-04-22 and 2026-12-31 that lowers LYB's senior unsecured (or equivalent long-term issuer) rating by one or more notches. Negative outlook changes without rating movement do NOT count. Includes rating withdrawals only if accompanied by a downgrade action. Resolves NO if neither agency downgrades, or if either agency upgrades LYB during the period.
Resolution Source
Moody's and S&P Global Ratings press releases and rating action announcements
Source Trigger
Credit rating agency reviews post-Q1 2026 — ratings pressure given GAAP losses, negative FCF environment, and dividend sustainability questions
Full multi-lens equity analysis